Stock Analysis

Elopak Full Year 2024 Earnings: EPS Misses Expectations

OB:ELO
Source: Shutterstock

Elopak (OB:ELO) Full Year 2024 Results

Key Financial Results

  • Revenue: €1.16b (up 2.2% from FY 2023).
  • Net income: €60.3m (down 12% from FY 2023).
  • Profit margin: 5.2% (down from 6.0% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: €0.23 (down from €0.25 in FY 2023).
earnings-and-revenue-growth
OB:ELO Earnings and Revenue Growth February 13th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Elopak EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%.

Looking ahead, revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Packaging industry in Europe.

Performance of the market in Norway.

The company's shares are up 5.2% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 2 warning signs for Elopak you should know about.

Valuation is complex, but we're here to simplify it.

Discover if Elopak might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About OB:ELO

Elopak

Manufactures and supplies paper-based packaging solutions for liquid food in Europe, the Middle East, Africa, Asia, the Americas, and internationally.

Excellent balance sheet and fair value.

Community Narratives

AstraZeneca's Oncology and Obesity Innovations Will Drive Revenue Growth by 10%
Fair Value SEK 2.55k|37.11% undervalued
Unike
Unike
Community Contributor
Leading the Charge in SME SaaS Innovation
Fair Value SEK 100.02|23.535% undervalued
Investingwilly
Investingwilly
Community Contributor
Brookfield Corporation is a solid BUY for a long-term portfolio
Fair Value CA$82.23|1.7389999999999999% overvalued
Jonataninho
Jonataninho
Community Contributor